Cite
HARVARD Citation
De Meulenaere, A. et al. (2021). An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma. Clinical and translational science. 14 (6), pp. 2300-2313. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De Meulenaere, A. et al. (2021). An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma. Clinical and translational science. 14 (6), pp. 2300-2313. [Online].